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Available online 22 April 2008A recent study published by Sjoblom and colleagues [T. Sjoblom, S. Jones, L.D. Wood, D.W. Parsons, J. Lin, T.D.
Barber, D. Mandelker, R.J. Leary, J. Ptak, N. Silliman, S. Szabo, P. Buckhaults, C. Farrell, P. Meeh, S.D. Markowitz, J.
Willis, D. Dawson, J.K. Willson, A.F. Gazdar, J. Hartigan, L. Wu, C. Liu, G. Parmigiani, B.H. Park, K.E. Bachman, N.
Papadopoulos, B. Vogelstein, K.W. Kinzler, V.E. Velculescu, The consensus coding sequences of human breast
and colorectal cancers. Science 314 (2006) 268-274.] performed comprehensive sequencing of 13,023 human
genes and identiﬁed mutations in genes speciﬁc to breast and colorectal tumors, providing insight into organ-
speciﬁc tumor biology. Here we present a systematic analysis of the functional classiﬁcations of Sjoblom's
“CAN” genes, a subset of these validated mutant genes, that identiﬁes novel organ-speciﬁc biological themes
and molecular pathways associated with disease-speciﬁc etiology. This analysis links four somatically
mutated genes associated with diverse oncological types to colorectal and breast cancers through established
TGF-β1-regulated interactions, revealing mechanistic differences in these cancers and providing potential
diagnostic and therapeutic targets.




BioinformaticsTumors arise from genetic alterations occurring within a single cell.
These are passed to daughter cells that accumulate additional muta-
tionswithin oncogenes, tumor-suppressor genes, and genomic stability
genes [2], which ultimately give rise to tumorigenesis. Although many
gene-speciﬁc mutations have been discovered in a wide range of
cancers, the reference human genome sequence and improved high-
throughput sequencing technologies provide the opportunity for an
unbiased approach to identify potentially importantmutations. Such an
approachwas used in a recent study by Sjoblom and colleagues [1] that
examined 14,661 transcripts from 13,023 genes (120,839 exons) from
the consensus coding sequences (CCDS) database [3] in 11 breast
tumors,11 colorectal tumors, and2normal control samples. A collection
of 1149 potential mutations was detected, from which a subset of 236
somatically mutated genes was experimentally validated. Statistical
analysis of these validated genes then identiﬁed a group of candidate
cancer genes (CAN genes) that had a higher baseline frequency ofenbush).
l rights reserved.mutation than expected by chance: 122 in breast and 69 in colorectal
cancers. Grouping organ-speciﬁc CAN mutant coding sequences into
biological themes based on Gene Ontology terms, Sjoblom et al. asso-
ciated these genes with speciﬁc cellular processes, including cellular
adhesion and motility, signal transduction, transcriptional regulation,
transport, cellular metabolism, intracellular trafﬁcking, and RNAmeta-
bolism, among others. Moreover, they identiﬁed signiﬁcant differences
in the mutation spectra of human breast and colorectal cancers, sug-
gesting distinct mutagenic and etiologic pathways.
While enlightening, this qualitative approach to gene functional
analysis does not take into account the relative representation of dif-
ferent functional classes associated with the entire collection of genes
surveyed. For example, since signal transduction genes are highly
represented in the CCDS database, the likelihood of a mutation oc-
curring by chance within these genes is greater than in other, less well
represented classes. With this in mind, we reanalyzed the CAN gene
dataset from Sjoblom et al. to identify biological functional classes and
pathways in which greater numbers of genes accumulate mutations
than one would expect by chance. Application of a statistically based
categorical representation approach allows one to move beyond look-
ing at individual genes to identify systems, rather than individual
genes, that may be associated with disease development and prog-
ression. The use of such methods, supplemented by text mining ap-
plied to PubMed abstracts associated with those genes, allowed us to
Table 1
EASE analysis: overrepresented functional classes of mutated CAN genes found in breast and colorectal cancer
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Fig. 1. Chilibot text-mining analysis of somatically mutated CAN genes in colorectal and breast cancers and their relationship to TGF-β regulation. (A) Somatically mutated CAN genes
in colorectal cancer. (B) Somatically mutated CAN genes in breast cancer. Light blue rectangles, queried terms. Green circles, interactive relationship (stimulative). Red circles,
interactive relationship (inhibitory). Yellow circles, interactive relationship (both stimulative and inhibitory). Gray circles, interactive relationship (neutral). Gray diamonds with
symbol, noninteractive (i.e., parallel) relationship. Gray diamonds without symbol, abstract co-occurrence only. Numbers within icons represent PubMed abstracts supporting each
association. ⁎Gene has not been clinically implicated in respective cancer state.
510 T.W. Chittenden et al. / Genomics 91 (2008) 508–511identify novel associations of numerous oncological types to colorectal
and breast cancers through established TGF-β1-regulated interactions.
Results and discussion
We analyzed the 69 CAN genes found by Sjoblom and associates [1]
to be mutated in colorectal cancer, using EASE [4]. EASE uses Fisher's
exact test to identify overrepresented functional classes relative to the
distribution of class assignments for genes in a reference dataset, in this
case the CCDS database from which the genes to be sequenced were
selected. Functional class assignments included Gene Ontology [5] as-
signments, chromosome location, phenotype, Pfamdomains [6], Swiss-
Prot keywords [7], BBID assignments [8], and the GenMAPP [9] and
KEGG pathway databases [10]. For CAN genes falling within those
overrepresented classes, we then used Chilibot [11] to perform text
mining to delineate associations between themutant genes and various
cancers.
We found 37 CAN genes associated with signiﬁcantly overrepre-
sented biological classes. Twenty of these, including APC, TP53, and
TGFBR2, have been previously associated with colorectal cancer; these
largely represent TGF-β signaling, disease mutation, alternative splic-
ing, and proteins containing MH1 and MH2 domains (Table 1). Al-
though none of the MH1-containing proteins were found to have
mutations in the active domain, of the MH2-containing proteins, 70%
of the CAN mutations identiﬁed by Sjoblom et al. were found within
theMH2 domain itself. This percentagewas not statistically signiﬁcant
according to χ2 analysis, however, due to the small sample size. The
remaining 17, including CAN genes associated with metalloendopep-
tidase activity and alternative splicing and those containing a ﬁbro-
nectin type III domain, have not been clinically linked to colorectal
cancer as determined by text mining [11].
The most prominent association revealed in this analysis was the
role of TGF-β1 regulation, with 17 of the 37 CAN genes having an
established relationship to this process (Fig. 1A). While mutationalNotes to Table 1:
The list of functional annotation classes analyzed includes GO terms for biological processes,m
family (Pfam) domain; Swiss-Prot keywords; Biological Biochemical Image Database (BBID);
Genes and Genomes (KEGG) pathways. Here Pop size is the number of CCDS genes assigned
particular annotation term. List size indicates the number of mutated genes with assignmen
term. The Fisher's exact column lists the p value from Fisher's exact test and the Prob ana
highlighted in yellow have not been clinically implicated in respective cancer types.inactivation of TGFBR2 is common in approximately 20–30% of all
colorectal cancers [12] and 70% of colorectal cancers with high degree
microsatellite instability [13], we ﬁnd that a signiﬁcant number of
additional TGF-β1-regulated genes are also mutated in colorectal
cancer, suggesting a much more signiﬁcant role for this pathway.
Of the 17 TGF-β1-regulated CAN genes, PTPRU and RUNX1T1 have
not been clinically linked to colorectal cancer. PTPRU is implicated in a
number of cellular processes, including cell growth, cell–cell recogni-
tion, cell adhesion, differentiation, mitotic cycle, and oncogenic trans-
formation. The expression of this gene is regulated, in part, by Ras and
upregulated in Jurkat T lymphoma cells [14]. In addition, overexpres-
sion of PTPRU in SW480 cells signiﬁcantly suppresses cell proliferation
and migration, suggesting that colorectal carcinomas with mutant
PTPRUmay be more aggressive [15]. Although RUNX1T1 (ETO) has not
been implicated in TGF-β1 regulation in colorectal cancer, TGF-β1 is a
potent endogenousnegative regulator of hematopoiesis, and the t(8;21)
(q22;q22) translocation of this gene,whichproduces a chimeric protein
(AML1–ETO), is one of the most common cytogenetic abnormalities in
acute myeloid leukemia [16]. These data implicate aberrant TGF-β1
regulation as a major contributor to the disease etiology of colorectal
cancer.
This high rate of hits in a single pathway is interesting, particularly
since other pathways known to be involved in colorectal cancer were
not targeted for mutations in the same manner. For example only 6 of
the 62 genes in the WNT/β-catenin pathway (SMAD2, SMAD3,
SMAD4, TP53, TCF7L2, APC) were identiﬁed, despite the fact that
this pathway is abnormally regulated in 80% of colorectal cancers [17].
Of the 122CANgenes Sjoblomand colleagues [1] identiﬁed in breast
cancer, we found 24 associatedwith overrepresented biological classes.
Only 5 CAN genes involved in cell adhesion molecule activity and
GTPase activation have a previously described relationship to breast
cancer [11] (Table 1). The remaining 19 CAN genes include those linked
to JNK activation and proteins containing spectrin-repeat domains.
Moreover, all enriched breast cancer terms can be linked to disease-olecular functions, and cellular components; chromosome location; phenotype; protein
and Gene Map Annotator and Pathway Proﬁler (GenMAPP) and Kyoto Encyclopedia o
to a particular annotation class. Pop hits is the number of CCDS sequences assigned to a
ts in each annotation class and List hits is the number associated with each particula
lysis column lists p values corrected for multiple testing via resampling. Genesf
r
511T.W. Chittenden et al. / Genomics 91 (2008) 508–511speciﬁc cytoskeleton regulation, representing a variety of cellular func-
tions including cell adhesion, migration, proliferation, apoptosis, and
differentiation. This suggests that cytoskeletal dysregulation may be a
major contributor to general breast cancer etiology. However, it is well
known that breast cancer is a molecularly diverse disease in which
subgroups are distinguished by hormone receptor status and gene
expressionproﬁles [18]. It is, therefore, unfortunate thatmore complete
data on these tumors are unavailable, as they might provide additional
insight.
Nevertheless, the available data allow one to draw some inte-
resting comparisons. Unlike colorectal cancer, somatic mutation in
breast cancer appears largely TGF-β1 independent. Only 3 of the 24
CAN genes identiﬁed in our analysis have a known association with
TGF-β1 regulation (Fig. 1B) and 2 of these (COL7A1 and SPTAN1) have
no clinical link to breast cancer. Type VII collagen (COL7A1) defects
cause recessive dystrophic epidermolysis bullosa (RDEB), a blistering
skin disorder often accompanied by epidermal cancers. Tumor–
stroma interactions mediated by collagen Type VII promote neoplasia
in RDEB patients and may contribute to their increased susceptibility
to squamous cell carcinoma. COL7A1 is activated by TGF-β1 via SMAD
transcription factors and JUN [19]. αII-Spectrin (SPTAN1) is upregu-
lated and associated with tumorigenesis in ovarian cancer. Moreover,
TGF-β1 promotes caspase 3-independent cleavage of SPTAN1, suggest-
ing mutation of a distinct apoptotic pathway in breast cancer [20].
Our systematic functional classiﬁcation, comprising statistical tests
for overrepresented biological themes and text mining, provides sup-
port for the manually derived themes of recent work by Sjoblom et al.
[1] and allowed us to identify additional mechanistic insights into the
differences betweenbreast and colorectal cancers. Inparticular,wehave
identiﬁed disease-speciﬁc functional classes and somatically mutated
molecular pathways that have not been previously reported. We have
also found evidence supporting a potentially more signiﬁcant role for
TGF-β1 regulation in colorectal tumorigenesis, a role that highlights
mechanistic differences between human breast and colorectal cancers.
Furthermore, our analysis identiﬁed four frequently mutated genes
(PTPRU, RUNX1T, COL7A, SPTAN1) associated with TGF-β regulation
that may represent diagnostic and therapeutic targets.
Given the rapid advances in next-generation sequencing technology,
we expect to see increasingnumbers of sequence-based studies thatwill
expand the catalog of potentially causative mutations in awide range of
disease states. As we have learned from gene expression studies,
functional analysis of the resulting gene lists usingnowwell-established
classiﬁcation systems such as GO can help put the work into an in-
tellectual framework that provides the opportunity for hypothesis gen-
eration andmechanistic interpretation. However, such analysis must be
applied rigorously to avoid reaching conclusions that reﬂect trends in
the data rather than patterns in the gene set that was sampled.
Materials and methods
Somatically mutated breast and colorectal candidate cancer genes (CAN genes)
identiﬁed by Sjoblom et al. [1] were subjected to a functional category representational
analysis using EASE [4] as implemented in MeV [21]. EASE uses Fisher's exact test to
identify functional classes that appear with a greater likelihood than by chance and
calculates associated p values based on the hypergeometric distribution. Here we
analyzed representation for Gene Ontology [5] assignments, chromosome location,
phenotype, Pfam domains [6], Swiss-Prot keywords [7], BBID assignments [8], and the
GenMAPP [9] and KEGG pathways [10]. In the analysis of GO terms, EASE uses the
structure of the GO hierarchy and performs an analysis at each level. One potential
limitation of this method is that it identiﬁes as signiﬁcant those pathways and
functional classes that have many genes that have accumulated mutations and does not
account for the mutation rates of individual genes.
Chilibot [11] was then used to identify associations between somatically mutated
CAN genes belonging to the enriched functional classes and disease state. Chilibot is a
Web-based application that uses natural language processing to search PubMed
abstracts for relationships between genes of interest. Each gene is compared with eachother gene in the query group and assigned a relationship (stimulatory, inhibitory,
neutral, parallel, or abstract co-occurrence) based on data in the abstract.
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